Drug Shortage Report for DEPO-PROVERA

Last updated on 2022-12-20 History
Report ID 131486
Drug Identification Number 00585092
Brand name DEPO-PROVERA STERILE AQUEOUS SUSPENSION 150 MG/ML
Common or Proper name DEPO-PROVERA
Company Name PFIZER CANADA ULC
Market Status CANCELLED POST MARKET
Active Ingredient(s) MEDROXYPROGESTERONE ACETATE
Strength(s) 150MG
Dosage form(s) SUSPENSION
Route of administration INTRAMUSCULAR INTRAMUSCULAR
Packaging size 1 x 1ML
ATC code G03AC
ATC description HORMONAL CONTRACEPTIVES FOR SYSTEMIC USE
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date 2021-07-23
Actual start date 2021-07-21
Estimated end date 2023-06-01
Actual end date 2022-08-05
Shortage status Resolved
Updated date 2022-12-20
Company comments Product discontinued, see posting 178953. Other presentation available, pre-filled syringes (DIN 02523493)
Health Canada comments
Tier 3 Status No
Contact Address 17300 TRANS-CANADA HIGHWAY
KIRKLAND, QUEBEC
CANADA H9J 2M5
Company contact information Customer Service / service à la clientèle : 1-888-999-8750 Email / courriel: PharmaCustomerServiceDept@pfizer.com

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v28 2022-12-20 French Compare
v27 2022-12-20 English Compare
v26 2022-07-21 English Compare
v25 2022-06-29 French Compare
v24 2022-06-29 English Compare
v23 2022-01-13 English Compare
v22 2021-09-30 French Compare
v21 2021-09-30 English Compare
v20 2021-07-22 English Compare
v19 2021-07-21 French Compare
v18 2021-07-21 English Compare
v17 2021-07-20 French Compare
v16 2021-07-20 English Compare
v15 2021-07-20 English Compare
v14 2021-07-14 French Compare
v13 2021-07-14 English Compare
v12 2021-05-21 French Compare
v11 2021-05-21 English Compare
v10 2021-04-09 French Compare
v9 2021-04-09 English Compare

Showing 1 to 20 of 28